Melar Acquisition Corp. I (MACI) is a special purpose acquisition company dedicated to identifying and merging with high-potential firms primarily in the technology and healthcare sectors. Backed by a seasoned management team, MACI seeks to capitalize on emerging growth opportunities by strategically targeting innovative companies that align with current market trends. With a strong commitment to driving long-term value and fostering innovation, MACI offers institutional investors a compelling opportunity to participate in transformative industries anticipated to experience significant advancements.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.54% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.32 |
| Price-to-Book | 1.42 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 39.05 |
| Quarterly Earnings Growth (YoY) | -45.40% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $16.00M |
| Float | $13.03M |
| % Insiders | 0.00% |
| % Institutions | 108.91% |
Volatility is currently contracting